Oxygen Transmission Rate Testing of Rigid Pharmaceutical Sheets: Methods, Standards and Applications

Oxygen transmission rate (OTR) testing of rigid pharmaceutical sheets is a critical quality control procedure that determines how effectively blister packaging materials protect tablets and capsules from oxidative degradation. This technical article explains the testing principles, applicable standards such as ASTM D3985, ASTM F1927, ISO 15105 and YBB 00082003, sample requirements, and practical considerations for pharmaceutical packaging manufacturers and accredited third-party laboratories.

Technical Overview

Rigid pharmaceutical sheets, also known as blister films or thermoformable pharmaceutical sheets, are the primary barrier materials used in blister packaging for tablets, capsules and other solid dosage forms. Because many active pharmaceutical ingredients and excipients are sensitive to oxidation, the oxygen barrier performance of these sheets has a direct impact on product shelf life, stability and regulatory compliance.

Oxygen transmission rate (OTR) testing quantifies the steady-state rate at which oxygen permeates through a sheet under controlled temperature, humidity and partial pressure conditions. The result is typically expressed in cm³/(m²·24h) under standard test conditions such as 23 °C and 0% or 50% relative humidity. Lower OTR values indicate stronger oxygen barrier properties.

Common rigid pharmaceutical sheet materials exhibit very different barrier performance levels:

• PVC rigid sheets: moderate oxygen barrier, widely used as the base substrate for blister packaging.
• PVDC-coated PVC (PVC/PVDC) sheets: significantly improved oxygen and moisture barrier due to the PVDC coating layer.
• PVC/PE and PVC/PVDC/PE composite sheets: multilayer structures combining formability with enhanced protection.
• Polypropylene (PP) rigid sheets: good moisture barrier with moderate oxygen barrier performance.
• PCTFE-based laminates (e.g., PVC/PCTFE, PE/PCTFE): premium ultra-high oxygen and moisture barrier used for highly sensitive drugs.
• Cyclic olefin copolymer (COC/COP) sheets: high transparency and strong moisture barrier for specialized applications.

Regulatory frameworks, including pharmacopoeial packaging standards and the Chinese YBB national packaging standards for pharmaceutical materials, require oxygen transmission rate verification as part of the registration dossier for direct-contact pharmaceutical packaging components.

Testing Samples

Sample Type 1: Monolayer Rigid Sheets

Monolayer materials such as standard PVC rigid sheets, PP rigid sheets and COC sheets are tested as flat die-cut specimens. The sheet surface must be clean, free of creases, pinholes and processing defects, and conditioned in a controlled environment before measurement.

Sample Type 2: Coated and Multilayer Composite Sheets

PVDC-coated PVC, PVC/PVDC/PE and PVC/PCTFE laminates are tested in their final laminate form so that the measured OTR reflects the combined barrier contribution of every functional layer. Specimens must be prepared with the coated or barrier layer correctly identified and oriented during clamping.

Sample Type 3: Thermoformed Blister Cavities

For whole-package verification, formed blister pockets or complete blister packages can be tested using package-specific fixtures, allowing manufacturers to evaluate how the thermoforming process (draw ratio, wall thinning) affects the real-world barrier performance of the formed cavity walls.

Testing Items

The core testing item is the oxygen transmission rate of the rigid pharmaceutical sheet, which may be characterized under multiple conditions:

• OTR at 23 °C and 0% RH (dry condition), in cm³/(m²·24h) or cm³/(m²·day·0.1 MPa).
• OTR at 23 °C and 50% RH or 90% RH (humidity-dependent barrier evaluation, particularly important for PVDC-coated materials whose barrier performance is humidity sensitive).
• OTR at elevated temperature and humidity conditions (e.g., 40 °C) for accelerated stability correlation studies.
• Oxygen permeance and oxygen permeability coefficient for material characterization and comparison.
• Comparative OTR of flat sheet versus thermoformed cavity wall to quantify barrier loss during forming.

Testing Methods

Coulometric Sensor Method (Equal-Pressure Method)

The specimen is mounted between two chambers. High-purity oxygen or oxygen-bearing carrier gas flows on one side, while oxygen-free carrier gas (nitrogen with a fixed humidity level) sweeps the other side. Oxygen permeating through the specimen is carried to a coulometric sensor, which generates a current proportional to the oxygen quantity. The steady-state signal is converted into the oxygen transmission rate. This method is specified in ASTM D3985, ASTM F1927 (with humidity control), ASTM F1307 for rigid packages, ISO 15105-2, and the coulometric sensor procedure in the YBB 00082003 standard for gas transmission determination.

Differential-Pressure Method (Manometric Method)

The specimen separates a high-pressure chamber from an evacuated low-pressure chamber. Oxygen permeating the specimen increases the pressure in the low-pressure chamber, and the pressure rise over time is used to calculate the gas transmission rate. This method is described in ASTM D1434, ISO 15105-1, GB/T 1038 and the pressure-based procedure of YBB 00082003. It requires no carrier gas and is suitable for high-barrier materials, although test humidity conditioning is more limited than with the coulometric method.

Sample Preparation and Conditioning

• Cut defect-free specimens larger than the test cell diameter, ensuring a flat and wrinkle-free test area.
• Condition specimens at the specified temperature and humidity (commonly 23 °C, 50% RH) for a minimum of 48 hours.
• Seal specimens into the test cells with appropriate sealing grease or gaskets to eliminate edge leakage.
• Purge the system thoroughly and allow sufficient time to reach steady-state permeation before recording data.
• Test at least three replicate specimens and report the mean value for quality release purposes.

Applications

Oxygen transmission rate testing of rigid pharmaceutical sheets supports multiple stages of the pharmaceutical packaging lifecycle:

• Incoming material inspection for pharmaceutical manufacturers verifying supplier certificates of analysis.
• Quality control and batch release testing by blister film producers.
• Pharmaceutical packaging registration and drug master file (DMF) submissions requiring YBB or pharmacopoeial compliance data.
• Material selection and formulation compatibility studies for oxidation-sensitive products such as vitamins, antibiotics, cardiovascular agents and biological dosage forms.
• Shelf-life modeling and accelerated stability studies correlating package barrier performance with product degradation kinetics.
• Process validation of thermoforming and coating operations, verifying that wall thinning or coating defects do not compromise barrier integrity.
• Comparative benchmarking of alternative barrier materials such as PVDC-coated PVC versus PCTFE laminates.

FAQ

Why is oxygen transmission rate testing important for rigid pharmaceutical sheets?

Many drugs degrade through oxidation, leading to loss of potency, discoloration or formation of impurities. OTR testing quantifies the protective capability of the blister material, enabling manufacturers to select appropriate packaging, justify shelf life and satisfy regulatory requirements for direct-contact packaging components.

Which test conditions should be selected?

Dry conditions (23 °C, 0% RH) provide the intrinsic barrier value, while humid conditions (typically 50% or 90% RH) reflect performance under real storage and climatic conditions. Humidity testing is especially important because PVDC-based barriers lose part of their oxygen barrier performance at high humidity, whereas PCTFE laminates remain largely unaffected.

What is a typical acceptance criterion?

Acceptance limits depend on the drug product sensitivity. Typical commercial PVC rigid sheets may show OTR values in the range of several cm³/(m²·24h), PVDC-coated grades reach values below 1 cm³/(m²·24h), and PCTFE-based laminates can achieve values in the range of 0.01 cm³/(m²·24h) or lower. The specification is agreed between the packaging supplier and the pharmaceutical customer based on stability data.

What is the difference between the coulometric and differential-pressure methods?

The coulometric method operates at equal pressure with a carrier gas stream and offers excellent sensitivity for high-barrier materials along with precise humidity control. The differential-pressure method measures pressure change directly without carrier gas and can simultaneously provide permeability coefficients, but it imposes a pressure differential across the specimen. Results from the two methods are generally comparable but should not be mixed within a single specification without validation.

How does thermoforming affect barrier performance?

During blister forming, cavity walls are stretched and thinned, which increases the local oxygen transmission rate. Testing formed cavities or finished packages, rather than only flat sheet, provides a more realistic assessment of the barrier actually delivered to the drug product.